Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zahar

Showing results (491-500 of 543) with videos related to

Pageof 55
Sort By:
Frontiers in Immunology|April 1, 2021
Novel Human Tenascin-C Function-Blocking Camel Single Domain NanobodiesSayda Dhaouadi, Rahma Ben Abderrazek, Thomas Loustau, et al.
Frontiers in Medicine|August 7, 2023
Prevalence and risk factors of toxigenic <i>Clostridioides difficile</i> asymptomatic carriage in 11 French hospitalsSarah Jolivet, Jeanne Couturier, Patrick Grohs, et al.
The Journal of Antimicrobial Chemotherapy|January 13, 2016
Colonization and infection with extended-spectrum β-lactamase-producing Enterobacteriaceae in ICU patients: what impact on outcomes and carbapenem exposure?François Barbier, Cécile Pommier, Wafa Essaied, et al.
The Journal of Hospital Infection|August 9, 2015
Hospital cost of Clostridium difficile infection including the contribution of recurrences in French acute-care hospitalsA Le Monnier, A Duburcq, J-R Zahar, et al.
American Journal of Respiratory and Critical Care Medicine|May 7, 2013
Pseudomonas aeruginosa ventilator-associated pneumonia. predictive factors of treatment failureBenjamin Planquette, Jean-Francois Timsit, Benoit Y Misset, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|August 4, 2012
Long-term control of vancomycin-resistant Enterococcus faecium at the scale of a large multihospital institution: a seven-year experienceS Fournier, F Brossier, N Fortineau, et al.
Intensive Care Medicine|November 30, 2019
Antimicrobial de-escalation in critically ill patients: a position statement from a task force of the European Society of Intensive Care Medicine (ESICM) and European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Critically Ill Patients Study Group (ESGCIP)Alexis Tabah, Matteo Bassetti, Marin H Kollef, et al.
Infection|July 6, 2018
Diabetes was the only comorbid condition associated with mortality of invasive pneumococcal infection in ICU patients: a multicenter observational study from the Outcomerea research groupMaité Garrouste-Orgeas, Elie Azoulay, Stéphane Ruckly, et al.
Intensive Care Medicine|April 18, 2018
Infection-related ventilator-associated complications in ICU patients colonised with extended-spectrum β-lactamase-producing EnterobacteriaceaeFrançois Barbier, Sébastien Bailly, Carole Schwebel, et al.
Intensive Care Medicine|June 16, 2018
Correction to: Infection-related ventilator-associated complications in ICU patients colonised with extended-spectrum β-lactamase-producing EnterobacteriaceaeFrançois Barbier, Sébastien Bailly, Carole Schwebel, et al.
Pageof 55

Showing results (491-500 of 543) with videos related to

Sort By:
Pageof 55
Frontiers in Immunology|April 1, 2021
Novel Human Tenascin-C Function-Blocking Camel Single Domain NanobodiesSayda Dhaouadi, Rahma Ben Abderrazek, Thomas Loustau, et al.
Frontiers in Medicine|August 7, 2023
Prevalence and risk factors of toxigenic <i>Clostridioides difficile</i> asymptomatic carriage in 11 French hospitalsSarah Jolivet, Jeanne Couturier, Patrick Grohs, et al.
The Journal of Antimicrobial Chemotherapy|January 13, 2016
Colonization and infection with extended-spectrum β-lactamase-producing Enterobacteriaceae in ICU patients: what impact on outcomes and carbapenem exposure?François Barbier, Cécile Pommier, Wafa Essaied, et al.
The Journal of Hospital Infection|August 9, 2015
Hospital cost of Clostridium difficile infection including the contribution of recurrences in French acute-care hospitalsA Le Monnier, A Duburcq, J-R Zahar, et al.
American Journal of Respiratory and Critical Care Medicine|May 7, 2013
Pseudomonas aeruginosa ventilator-associated pneumonia. predictive factors of treatment failureBenjamin Planquette, Jean-Francois Timsit, Benoit Y Misset, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|August 4, 2012
Long-term control of vancomycin-resistant Enterococcus faecium at the scale of a large multihospital institution: a seven-year experienceS Fournier, F Brossier, N Fortineau, et al.
Intensive Care Medicine|November 30, 2019
Antimicrobial de-escalation in critically ill patients: a position statement from a task force of the European Society of Intensive Care Medicine (ESICM) and European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Critically Ill Patients Study Group (ESGCIP)Alexis Tabah, Matteo Bassetti, Marin H Kollef, et al.
Infection|July 6, 2018
Diabetes was the only comorbid condition associated with mortality of invasive pneumococcal infection in ICU patients: a multicenter observational study from the Outcomerea research groupMaité Garrouste-Orgeas, Elie Azoulay, Stéphane Ruckly, et al.
Intensive Care Medicine|April 18, 2018
Infection-related ventilator-associated complications in ICU patients colonised with extended-spectrum β-lactamase-producing EnterobacteriaceaeFrançois Barbier, Sébastien Bailly, Carole Schwebel, et al.
Intensive Care Medicine|June 16, 2018
Correction to: Infection-related ventilator-associated complications in ICU patients colonised with extended-spectrum β-lactamase-producing EnterobacteriaceaeFrançois Barbier, Sébastien Bailly, Carole Schwebel, et al.
Pageof 55